UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

European journal of endocrinology, 2020-06, Vol.182 (6), p.595-605

2020

Volltextzugriff (PDF)

Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours

Endocrine-related cancer, 2003-12, Vol.10 (4), p.451-458

2003

Volltextzugriff (PDF)

Octreotide

The New England journal of medicine, 1996-01, Vol.334 (4), p.246-254

1996

Volltextzugriff (PDF)

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro

Journal of molecular endocrinology, 2009, Vol.42 (1), p.47-56

2009

Volltextzugriff (PDF)

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

Oncotarget, 2018-03, Vol.9 (19), p.14791-14802

2018

Volltextzugriff (PDF)

Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor

Molecular and cellular endocrinology, 2006-06, Vol.251 (1), p.103-111

2006

Volltextzugriff (PDF)

Control of powdery mildew on glasshouse-grown roses and tomatoes in the Netherlands using anhydrous milk fat and soybean oil emulsions

New Zealand plant protection, 2015, Vol.68, p.380-388

2015

Volltextzugriff (PDF)

The role of somatostatin and dopamine D2 receptors in endocrine tumors

Endocrine-related cancer, 2011-12, Vol.18 (6), p.R233-R251

2011

Volltextzugriff (PDF)

Pituitary tumours: the sst/D2 receptors as molecular targets

Molecular and cellular endocrinology, 2010-09, Vol.326 (1-2), p.89-98

2010

Volltextzugriff (PDF)

In Vitro Characterization of Somatostatin Receptors in the Human Thymus and Effects of Somatostatin and Octreotide on Cultured Thymic Epithelial Cells

Endocrinology (Philadelphia), 1999-01, Vol.140 (1), p.373-380

1999

Volltextzugriff (PDF)

The role of somatostatin analogs in Cushing's disease

Pituitary, 2004-12, Vol.7 (4), p.257-264

2004

Volltextzugriff (PDF)

[ 111In-DTPA-D-Phe 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

Life sciences (1973), 1991, Vol.49 (22), p.1583-1591

1991

Volltextzugriff (PDF)

IGF-I Bioactivity in an Elderly Population

Diabetes (New York, N.Y.), 2010-02, Vol.59 (2), p.505-508

2010

Volltextzugriff (PDF)

Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?

Journal of translational medicine, 2012-11, Vol.10 (S3), p.P22-P22, Article P22

2012

Volltextzugriff (PDF)

Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro

The journal of clinical endocrinology and metabolism, 2000-04, Vol.85 (4), p.1719-1726

2000

Volltextzugriff (PDF)

Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors : consequences with regard to diagnosis, localization, and therapy

The journal of clinical endocrinology and metabolism, 1990-09, Vol.71 (3), p.566-574

1990

Volltextzugriff (PDF)

The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas

European journal of endocrinology, 2007-04, Vol.156 Suppl 1, p.S1

2007

Volltextzugriff (PDF)

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

Cancer research (Chicago, Ill.), 1998-02, Vol.58 (3), p.437-441

1998

Volltextzugriff (PDF)

Interferon-α-2a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas

The journal of clinical endocrinology and metabolism, 1999-09, Vol.84 (9), p.3336-3343

1999

Volltextzugriff (PDF)

O80 Understanding the mechanisms of mesenteric fibrosis in small intestinal neuroendocrine tumours

Gut, 2024-06, Vol.73 (Suppl 1), p.A49-A49

2024

Volltextzugriff (PDF)

Safety Aspects of Non-ionic Surfactant Vesicles: A Toxicity Study Related to the Physicochemical Characteristics of Non-ionic Surfactants

Journal of pharmacy and pharmacology, 1992-04, Vol.44 (4), p.287-294

1992

Volltextzugriff (PDF)

ANNIVERSARY REVIEW: Octreotide, 40 years later

European journal of endocrinology, 2019-11, Vol.181 (5), p.R173-R183

2019

Volltextzugriff (PDF)

Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects

Journal of endocrinological investigation, 2005, Vol.28 (11 Suppl International), p.36-42

2005

Volltextzugriff (PDF)

PS1-103 Pancreatic adenocarcinoma: Understanding differences in interferon pathways to optimize oncolytic virotherapy

Cytokine (Philadelphia, Pa.), 2011-10, Vol.56 (1), p.43-44

2011

Volltextzugriff (PDF)

Epigenetic regulation of SST 2 expression in small intestinal neuroendocrine tumors

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1184436

2023

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(183)
Mit Volltextzugriff
(173)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(54)
Biological And Medical Sciences
(48)
Medical Sciences
(38)
Male
(24)
Female
(22)
Animals
(21)
Pharmacology. Drug Treatments
(18)
Somatostatin - Analogs & Derivatives
(17)
Adult
(16)
Middle Aged
(15)
Aged
(13)
Rats
(12)
Receptors, Somatostatin - Metabolism
(12)
Octreotide - Therapeutic Use
(11)
Somatostatin
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Octreotide - Analogs & Derivatives
(10)
Somatostatin - Therapeutic Use
(9)
Endocrinopathies
(8)
Mice
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly

Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours

Octreotide

Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor

Control of powdery mildew on glasshouse-grown roses and tomatoes in the Netherlands using anhydrous milk fat and soybean oil emulsions

The role of somatostatin and dopamine D2 receptors in endocrine tumors

Pituitary tumours: the sst/D2 receptors as molecular targets

In Vitro Characterization of Somatostatin Receptors in the Human Thymus and Effects of Somatostatin and Octreotide on Cultured Thymic Epithelial Cells

The role of somatostatin analogs in Cushing's disease

[ 111In-DTPA-D-Phe 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation

IGF-I Bioactivity in an Elderly Population

Macrophage-fibroblast interplay: a target for neuropeptide-based treatment of fibrotic disease?

Somatostatin Receptor Subtypes in Human Thymoma and Inhibition of Cell Proliferation by Octreotide in Vitro

Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors : consequences with regard to diagnosis, localization, and therapy

The role of somatostatin and dopamine receptors as molecular targets for the treatment of patients with pituitary adenomas

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

Interferon-α-2a Is a Potent Inhibitor of Hormone Secretion by Cultured Human Pituitary Adenomas

O80 Understanding the mechanisms of mesenteric fibrosis in small intestinal neuroendocrine tumours

Safety Aspects of Non-ionic Surfactant Vesicles: A Toxicity Study Related to the Physicochemical Characteristics of Non-ionic Surfactants

ANNIVERSARY REVIEW: Octreotide, 40 years later

Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects

PS1-103 Pancreatic adenocarcinoma: Understanding differences in interferon pathways to optimize oncolytic virotherapy

Epigenetic regulation of SST 2 expression in small intestinal neuroendocrine tumors

Aktive Filter

Suchergebnisse filtern